Evaluating the influence of selection markers on obtaining selected pools and stable cell lines in human cells

被引:39
作者
Lanza, Amanda M. [1 ]
Kim, Do Soon [1 ]
Alper, Hal S. [1 ,2 ]
机构
[1] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA
[2] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA
基金
美国国家科学基金会;
关键词
Hygromycin B; Mammalian selection marker; Neomycin; Puromycin; Zeocin; MAMMALIAN-CELLS; CHO CELLS; RECOMBINANT PROTEIN; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; RESISTANCE; DNA; INTEGRATION; CULTURE; VECTOR;
D O I
10.1002/biot.201200364
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Selection markers are common genetic elements used in recombinant cell line development. While several selection systems exist for use in mammalian cell lines, no previous study has comprehensively evaluated their performance in the isolation of recombinant populations and cell lines. Here we examine four antibiotics, hygromycin B, neomycin, puromycin, and Zeocin, and their corresponding selector genes, using a green fluorescent protein (GFP) as a reporter in two model cell lines, HT1080 and HEK293. We identify Zeocin as the best selection agent for cell line development in human cells. In comparison to the other selection systems, Zeocin is able to identify populations with higher fluorescence levels, which in turn leads to the isolation of better clonal populations and less false positives. Furthermore, Zeocin-resistant populations exhibit better transgene stability in the absence of selection pressure compared to other selection agents. All isolated Zeocin-resistant clones, regardless of cell type, exhibited GFP expression. By comparison, only 79% of hygromycin B-resistant, 47% of neomycin-resistant, and 14% of puromycin-resistant clones expressed GFP. Based on these results, we rank Zeocin > hygromycin B approximate to puromycin > neomycin for cell line development in human cells. Furthermore, this study demonstrates that selection marker choice does indeed impact cell line development.
引用
收藏
页码:811 / +
页数:2
相关论文
共 45 条
[1]   MECHANISM OF PUROMYCIN ACTION - FATE OF RIBOSOMES AFTER RELEASE OF NASCENT PROTEIN CHAINS FROM POLYSOMES [J].
AZZAM, ME ;
ALGRANATI, ID .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (12) :3866-3869
[2]   CHANGES IN DNA DISTRIBUTIONS AND PLOIDY OF CHO CELLS AS A FUNCTION OF TIME IN CULTURE [J].
BARRANCO, SC ;
SHILKUN, K ;
NICHOLS, S ;
BOERWINKLE, WR ;
ADAMS, EG ;
BHUYAN, BK .
IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1981, 17 (08) :730-734
[3]   CONSTRUCTION OF A FUSION GENE THAT CONFERS RESISTANCE AGAINST HYGROMYCIN-B TO MAMMALIAN-CELLS IN CULTURE [J].
BERNARD, HU ;
KRAMMER, G ;
ROWEKAMP, WG .
EXPERIMENTAL CELL RESEARCH, 1985, 158 (01) :237-243
[4]   Selection methods for high-producing mammalian cell lines [J].
Browne, Susan M. ;
Al-Rubeai, Mohamed .
TRENDS IN BIOTECHNOLOGY, 2007, 25 (09) :425-432
[5]   New selectable host-marker systems for multiple genetic manipulations based on TRP1, MET2 and ADE2 in the methylotrophic yeast Hansenula polymorpha [J].
Cheon, Seon Ah ;
Choo, Jinho ;
Ubiyvovk, Vera M. ;
Park, Jeong-Nam ;
Kim, Moo Woong ;
Oh, Doo-Byoung ;
Kwon, Ohsuk ;
Sibirny, Andriy A. ;
Kim, Jeong-Yoon ;
Kang, Hyun Ah .
YEAST, 2009, 26 (09) :507-521
[6]   A Study of Monoclonal Antibody-Producing CHO Cell Lines: What Makes a Stable High Producer? [J].
Chusainow, Janet ;
Yang, Yuan Sheng ;
Yeo, Yessna H. M. ;
Toh, Poh Choo ;
Asvadi, Parisa ;
Wong, Niki S. C. ;
Yap, Miranda G. S. .
BIOTECHNOLOGY AND BIOENGINEERING, 2009, 102 (04) :1182-1196
[7]   Guidelines to cell engineering for monoclonal antibody production [J].
Costa, A. Rita ;
Rodrigues, M. Elisa ;
Henriques, Mariana ;
Azeredo, Joana ;
Oliveira, Rosario .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 74 (02) :127-138
[8]   EVALUATION OF SELECTABLE MARKERS FOR RICE TRANSFORMATION [J].
DEKEYSER, R ;
CLAES, B ;
MARICHAL, M ;
VANMONTAGU, M ;
CAPLAN, A .
PLANT PHYSIOLOGY, 1989, 90 (01) :217-223
[9]   Genetic characterization of CHO production host DG44 and derivative recombinant cell lines [J].
Derouazi, M ;
Martinet, D ;
Schmutz, NB ;
Flaction, R ;
Wicht, M ;
Bertschinger, M ;
Hacker, DL ;
Beckmann, JS ;
Wurm, FM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (04) :1069-1077
[10]   Expression systems for therapeutic glycoprotein production [J].
Durocher, Yves ;
Butler, Michael .
CURRENT OPINION IN BIOTECHNOLOGY, 2009, 20 (06) :700-707